Emergency cardiovascular consultations by women: Is management different in women and men?;Manejo clínico de las mujeres que consultan en urgencias por patología cardiovascular: ¿existen diferencias respecto a los hombres?

Emergencias

Volumn 24, Issue 4, 2012, Pages 325-331

  Riesgo García, Alba ^a  

^a Hospital Universitario Central de Oviedo   (Spain)

Author keywords

Acute coronary syndrome; Atrial fibrillation; Cardiovascular diseases; Chest pain; Emergency health services; Heart failure

Indexed keywords

EID: 84865512379     PISSN: 11376821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. World Health Organization Sattistical Information System 2010. (Consultado 30 Julio 2011). Disponible en: http://www.who.int/whosis/.
2. Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2009. Vital Health Stat 10. No. 247; 2010.
3. Wenger N. Coronary Heart Disease: The Female Heart Is Vulnerable. Prog Cardiovasc Dis. 2003;46:199-229.
4. Red Alert for Women's heart ESC. Nov 2009. (Consultado 30 Julio 2011). Disponible en: http://www.escardio.org/about/what/advocacy/ EuroHeart/Documents/WomensHearts-RedAlert.pdf
5. Murphy E, Steenbergen C. Gender-based differences in mechanism of protection in myocardial ischemia-reperfusion injury. Cardiovascular Research. 2007;75:478-86.
6. Bragulat E, López B, Miró O, Coll-Vinent B, Jiménez S, Aparicio MJ, et al. Análisis de la actividad de una unidad estructural de dolor torácico en un servicio de urgencias hospitalaria. Rev Esp Cardiol. 2007;60:276-84.
7. Douglas PS, Ginsburg GS, The evaluation of chest pain in women. N Engl J Med. 1996;334:1311-5.
8. Riesgo A, Bragulat E, López-Barbeito B, Sánchez M, Miró O. Aproximación diagnóstica al dolor torácico en urgencias: ¿existen diferencias entre mujeres y hombres? Emergencias. 2008;20:399-404.
9. Kaul P, Chang WC, Westerhourt CM, Graham MM, Amstrong PW. Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. CMAJ. 2007;117:1193-9.
10. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476-84.
11. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med. 1982;306:1018-22.
12. Santini M, De Ferrari GM, Pandozi C, Alboni P, Capucci A, Disertori M, et al. FIRE Investigators. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admision. Data from the atrial fibrillation/flutter Italian Registry (FIRE). Ital Heart J. 2004;5:205-13.
13. Dialy B, Lehman H, Schumacher DN, Steiman RT, Meissner MD. Hospitalization for arrhythmias in the United States: Importance of atrial fibrillation. J Am Coll Cardiol. 1992:19:41A.
14. Heeringa J, Van der Kruip DAM, Hofman A, Kors JA, Van Herpen G, Stricker B, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949-53.
15. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age, distribution and gender of patients with atrial fibrillation. Arch Intern Med. 1995;155:469-73.
16. Cea-Calvo L, Redón J, Lozano JV, Fernández-Pérez C, Martí-Canales JC, Llisterri JL, et al. Prevalencia de fibrilación auricular en la población española de 60 o más años de edad. Estudio PREV-ICTUS. Rev Esp Cardiol. 2007;60:616-24.
17. Almendral J, Martín E, Medina O, Peinado R, Pérez I, Ruiz R, et al. Guía de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas. Rev Esp Cardiol. 2001;54:307-67.
18. Dagres N, Nieruwlaat R, Vardas PE, Andersen D, Lévy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients witj atrial fibrillation in europe. A report from the Euro Heart Survey Study on Atrial Fibrillation. J Am Coll Cardiol. 2007;49:572-7.
19. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, et al. The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation. Ann Intern Med. 2009;151:297-305.
20. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-52.
21. Riesgo A, Sant E, Benito L, Hoyo J, Miró O, Monte Ll, et al. Diferencias de género en el manejo de los pacientes con fibrilación auricular: anáisis de base poblacional en un área básica de salud. Rev Esp Cardiol. 2011;64:233-6.
22. Ratjore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 2002;347:1403-11.
23. García-Acuña JM, González-Juanatey JR, Alegría Ezquerra E, González Maqueda I, Listerri JL. La fibrilación auricular permanente en las enfermedades cardiovasculares en España. Estudio CARDIOTENS 1999. Rev Esp Cardiol. 2002;55:943-52.
24. Roten L, Rimoldi SL, Schwick N, Sakata T, Heimgartner C, Fuhrer J, et al. Gender Differences in Patients Referred for Atrial Fibrillation Management to a Tertiary Center. Pace. 2009;31:622-6.
25. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011;305:2080-7.
26. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study. JAMA. 2003;290:1049-56.
27. Rienstra M, Van Veldhuisen DJ, Hagens VE, Ranchor AV, Veeger NJGM, et al. for the RACE investigators. Gender-Related Differences in Rhythm Control Treatment in Persistent Atrial Fibrillation. Data of the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol. 2005;46:1298-306.
28. Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M, et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation. 2001;103:2365-70.
29. ESC Guidelines for the diagnosis and treatment of acure and chronic heart failure 2008. Eur Heart Journal. 2008;29:2388-442.
30. Anguita Sánchez M, Crespo Leiro MG, De Teresa Galván E, Jiménez Navarro M, Alonso-Pulpón L, Muñiz García J, en representación de los investigadores del estudio PRICE. Prevalencia de la insuficiencia cardiaca en la población general española mayor de 45 años. Estudio PRICE. Rev Esp Cardiol. 2008;61:1041-9.
31. Jiménez-Navarro M, García-Pinilla JM, Anguita Sánchez M, Martínez A, Torres F; Investigadores del registro RAIC. Características demográficas de los pacientes ingresados por insuficiencia cardíaca en Andalucía: resultados del estudio RAIC (Registro Andaluz de Insuficiencia Cardiaca). Rev Esp Cardiol. 2006;41:107-13.
32. Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis. 2004;46:287-95.
33. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival alter Honest of congestive heart failure en the Framminghan Heart Study subjets. Circulation. 1993;88:107-15.
34. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol. 2003;42:2128-34.
35. Lenzen MJ, Rosengren A, Scholte op Reimer WJM, Follath F, Boersma E, Simoons ML, et al. Management of patients with heart failure in clinical practice: differences between men and women. An Med Interna. 2005;22:515-9.
36. Jiménez-Navarro MF, Anguita-Sánchez M. Insuficiencia cardiaca en la mujer. Diferencias de sexo en España. Rev Esp Cardiol. 2008;8:23D-29D.
37. Galvao M, Kalman J, Demarco T, Fonarow GC, Galvin K, Ghali JK, et al. On behalf of the ADHERE scientific advisory comitee, investigators, coordinators, and study group. Gender differences in in-hospital Management and outcomes in patients with descompensated herat failure: analysis from de Acute Descompensated Heart Failure National Registry (ADHERE). Cardiac Failure. 2006;12:100-7.
38. Riesgo A, Herrero P, Llorens P, Jacob J, Martín-Sánchez FJ, Bragulat E, et al, en nombre del grupo EAFHE. Influencia del sexo del paciente en la forma de presentación y en el tratamiento de la insuficiencia cardíaca aguda en los servicios de Urgencias españoles. Med Clin (Barc). 2010;134:671-7.
39. Canto JG, Goldberg RJ, Hand MH, Bonow RO, Sopko G, Pepine CJ, et al. Symptom presentation of women with acute coronary syndromes. Myth vs reality. Arch Intern Med. 2007;167:2405-13.
40. Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz JM, on behalf of AIM Plus Investigators. Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20290 patients from the AMIS Plus Registry. Heart. 2007;93:1369-75.
41. Bodí V, Fácila L, Sanchís J, Llácer A, Ferrero JA, Chorro FJ. Diferencias entre sexos en pacientes con sospecha de síndrome coronario agudo sin elevación del segmento ST. Implicaciones en el tratamiento intervencionista. Rev Esp Cardiol. 2003;56:412-6.
42. Alfredsson J, Stenestrand U, Wallentin L, Swahn E. Gender differences in management and outcome in non-ST-elevation acute coronary syndrome. Heart. 2007;93:1357-62.
43. Isaksson RM, Holmgren L, Lundblad D, Brulin C, Eliasson M. Time trends in symptoms and prehospital delay time in women vs. men with myocardial infarction over a 15-year period. The Northern Sweden MONICA study. Eur J Cardiovasc Nurs. 2008;7:152-8.
44. Ting HH, Bradley EH, Wang Y, Lichtman JH, Nallamothu BK, Sullivan MD, et al. Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med. 2008;168:959-68.
45. Sánchez M. Tratamiento del infarto de miocardio con elevación del ST: ¿una guerra de sexos? Emergencias 2011;22:83-4.
46. Carbajosa-Dalmau J, Llorens P, Diéguez-Zaragoza S, Carratalá-Peralesa JM, Díaz-Dámaso J, Martínez-Beloquia E, et al. Influencia del sexo del paciente en el manejo del síndrome coronario agudo con elevación del ST en los servicios de urgencias. Emergencias. 2011;23:87-92.
47. Riesgo A, Miró O, López De Sá E, Sánchez M. Comparación del manejo del infarto de miocardio sin elevación del ST durante la asistencia urgente en función del sexo del paciente. Rev Esp Cardiol. 2011; en prensa.
48. Champney KP, Frederick PD, Bueno H, Parashar S, Foody J, Merz CNB, et al. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart. 2009;95:895-9.
49. Aguado-Romeo MJ, Márquez-Calderón S, Buzón-Barrera ML, for the Medical Practice Variations Andalusian Group. Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures. BMC Health Services Research. 2007;7:110.
50. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women-2011 Update. A Guideline From the American Heart Association. Circulation. 2011;123:1243-62.